Package 49884-485-11

{"route": ["ORAL"], "spl_id": "9bb82767-a8f0-4956-875f-3d89731e1049", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["103968", "198430", "252478", "252479", "851748", "851750", "851752"], "spl_set_id": ["003663e5-c0c7-4fc1-a64d-313f2a5b10d2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Endo USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK (49884-485-11)", "package_ndc": "49884-485-11", "marketing_start_date": "20151216"}], "brand_name": "Lamotrigine", "product_id": "49884-485_9bb82767-a8f0-4956-875f-3d89731e1049", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49884-485", "generic_name": "Lamotrigine", "labeler_name": "Endo USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "50 mg/1"}], "application_number": "ANDA204158", "marketing_category": "ANDA", "marketing_start_date": "20151216", "listing_expiration_date": "20261231"}